Skip to content
Disclosery

Skorpios Trust

Follow

13F filer, CIK 1869333, LIMASSOL, Cyprus

Skorpios Trust reported $53,189,191 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-10-29.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001123292-25-000594

Period
2025-09-30
Reported value
$53.2M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
STOKreduced-1,000,000-$23.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001123292-25-000594, largest first. % of portfolio is the value over $53,189,191, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 14,443,681 shares; 2024Q1: 14,443,681 shares; 2024Q2: 10,843,681 shares; 2024Q3: 8,906,181 shares; 2024Q4: 6,906,181 shares; 2025Q1: 6,906,181 shares; 2025Q2: 3,256,181 shares; 2025Q3: 2,256,181 shares 2,256,181$53M99.68%-1,000,000Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,686 shares; 2024Q1: 1,686 shares; 2024Q2: 1,686 shares; 2024Q3: 1,686 shares; 2024Q4: 1,686 shares; 2025Q1: 1,686 shares; 2025Q2: 1,686 shares; 2025Q3: 1,686 shares 1,686$169K0.32%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001123292-25-000594 base2025-10-29acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001123292-25-000594 Quarter ended 2025-09-302025-10-29acceptance time not in the bulk data set
13F-HR 0001123292-25-000327 Quarter ended 2025-06-302025-07-30acceptance time not in the bulk data set
13F-HR 0001123292-25-000200 Quarter ended 2025-03-312025-05-06acceptance time not in the bulk data set
13F-HR 0001123292-25-000035 Quarter ended 2024-12-312025-02-05acceptance time not in the bulk data set
13F-HR 0001123292-24-000318 Quarter ended 2024-09-302024-10-23acceptance time not in the bulk data set
13F-HR 0001123292-24-000211 Quarter ended 2024-06-302024-08-05acceptance time not in the bulk data set
13F-HR 0001123292-24-000117 Quarter ended 2024-03-312024-04-26acceptance time not in the bulk data set
13F-HR 0001123292-24-000017 Quarter ended 2023-12-312024-02-06acceptance time not in the bulk data set
13F-HR 0001123292-23-000136 Quarter ended 2023-09-302023-11-06acceptance time not in the bulk data set
13F-HR 0001123292-23-000090 Quarter ended 2023-06-302023-08-03acceptance time not in the bulk data set
13F-HR 0001123292-23-000055 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001567619-23-001995 Quarter ended 2022-12-312023-02-07acceptance time not in the bulk data set
13F-HR 0001567619-22-019234 Quarter ended 2022-09-302022-11-07acceptance time not in the bulk data set
13F-HR 0001567619-22-014738 Quarter ended 2022-06-302022-08-02acceptance time not in the bulk data set
13F-HR 0001567619-22-008844 Quarter ended 2022-03-312022-04-22acceptance time not in the bulk data set
13F-HR 0001567619-22-001885 Quarter ended 2021-12-312022-01-27acceptance time not in the bulk data set